Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for ALX Oncology Holdings Inc have a median target of 6.00, with a high estimate of 25.00 and a low estimate of 3.00. The median estimate represents a 180.37% increase from the last price of 2.14.
High | 1,068.2% | 25.00 |
Med | 180.4% | 6.00 |
Low | 40.2% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -1.50% |
Average growth rate | -15.30% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -33.33% |
More ▼